Extensive cerebral white matter involvement in a patient with NMO spectrum disorder

Xavier Ayrignac1, Clarisse Carra Dalière2, Elodie Nerrant2

  • 1CHU Montpellier, France xavier.ayrignac@yahoo.fr.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|May 24, 2014
PubMed

Insights

Neuromyelitis optica (NMO) spectrum disorder can involve the brain, with rare cases showing extensive white matter T2 hyperintensities on MRI. This suggests a potential for progressive cerebral involvement in some NMO patients.

Area of Science:

  • Neuroimmunology
  • Neuroimaging

Background:

  • Neuromyelitis optica (NMO) spectrum disorder is an autoimmune condition primarily affecting the optic nerves and spinal cord.
  • Brain Magnetic Resonance Imaging (MRI) abnormalities are reported in up to 60% of NMO patients, but white matter T2 hyperintensities are uncommon.

Observation:

  • A case study of a 49-year-old woman with a long-standing diagnosis of NMO spectrum disorder is presented.
  • This patient exhibited diffuse cerebral white matter T2-weighted hyperintensities on brain MRI.

Findings:

  • The observed diffuse white matter T2 hyperintensities in this NMO patient are rarely reported.
  • This finding challenges the typical understanding of NMO's cerebral involvement.

Implications:

  • The case suggests that some patients with NMO spectrum disorder may develop significant and progressive cerebral white matter lesions.
  • Further research is warranted to understand the mechanisms and clinical significance of extensive cerebral involvement in NMO.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
20
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
11
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49